These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24151317)

  • 1. Recent advances in humanized mice: accelerating the development of an HIV vaccine.
    Tager AM; Pensiero M; Allen TM
    J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S121-4. PubMed ID: 24151317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice.
    Dudek TE; Allen TM
    J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S150-4. PubMed ID: 24151322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for HIV/AIDS research.
    Hatziioannou T; Evans DT
    Nat Rev Microbiol; 2012 Dec; 10(12):852-67. PubMed ID: 23154262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized Mouse Models for Human Immunodeficiency Virus Infection.
    Marsden MD; Zack JA
    Annu Rev Virol; 2017 Sep; 4(1):393-412. PubMed ID: 28746819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.
    Sarin PS; Mora CA; Naylor PH; Markham R; Schwartz D; Kahn J; Heseltine P; Gazzard B; Youle M; Rios A
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):401-7. PubMed ID: 7580834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection.
    Ayash-Rashkovsky M; Borkow G; Davis HL; Moss RB; Bartholomew R; Bentwich Z
    FASEB J; 2005 Jul; 19(9):1152-4. PubMed ID: 15833766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing antibodies and vaccine design against HIV-1 infection.
    Wang Q; Zhang L
    Front Med; 2020 Feb; 14(1):30-42. PubMed ID: 31858368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New paradigms for HIV/AIDS vaccine development.
    Picker LJ; Hansen SG; Lifson JD
    Annu Rev Med; 2012; 63():95-111. PubMed ID: 21942424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.
    Akkina R; Allam A; Balazs AB; Blankson JN; Burnett JC; Casares S; Garcia JV; Hasenkrug KJ; Kashanchi F; Kitchen SG; Klein F; Kumar P; Luster AD; Poluektova LY; Rao M; Sanders-Beer BE; Shultz LD; Zack JA
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):109-19. PubMed ID: 26670361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for the study of human immunodeficiency virus infections.
    Letvin NL
    Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response.
    Sui Y; Lewis GK; Wang Y; Berckmueller K; Frey B; Dzutsev A; Vargas-Inchaustegui D; Mohanram V; Musich T; Shen X; DeVico A; Fouts T; Venzon D; Kirk J; Waters RC; Talton J; Klinman D; Clements J; Tomaras GD; Franchini G; Robert-Guroff M; Trinchieri G; Gallo RC; Berzofsky JA
    J Clin Invest; 2019 Mar; 129(3):1314-1328. PubMed ID: 30776026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in mucosal HIV vaccine development: lessons from non-human primate models.
    Tuero I; Robert-Guroff M
    Viruses; 2014 Aug; 6(8):3129-58. PubMed ID: 25196380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.
    Gao Y; Wijewardhana C; Mann JFS
    Front Immunol; 2018; 9():345. PubMed ID: 29541072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multicomponent candidate vaccine for HIV-1.
    Kim JJ; Ayyavoo V; Bagarazzi ML; Chattergoon M; Boyer JD; Wang B; Weiner DB
    Vaccine; 1997 Jun; 15(8):879-83. PubMed ID: 9234538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.